Your browser doesn't support javascript.
loading
Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models.
Clin Cancer Res ; 11(8): 3045-54, 2005 Apr 15.
Article in En | MEDLINE | ID: mdl-15837760
Search on Google
Database: MEDLINE Main subject: Apoptosis / Alkyl and Aryl Transferases / Angiogenesis Inhibitors / Xenograft Model Antitumor Assays / Imidazoles / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Year: 2005 Type: Article
Search on Google
Database: MEDLINE Main subject: Apoptosis / Alkyl and Aryl Transferases / Angiogenesis Inhibitors / Xenograft Model Antitumor Assays / Imidazoles / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Year: 2005 Type: Article